600
Participants
Start Date
May 17, 2021
Primary Completion Date
July 18, 2022
Study Completion Date
July 18, 2022
observational study
no study drug involved, observational study.
Research Site, Shanghai
Research Site, Beijing
Research Site, Guangzhou
Research Site, Shenzhen
Research Site, Shijiazhuang
Research Site, Taihe
Research Site, Nanchang
Research Site, Shenyang
Research Site, Taiyuan
Research Site, Yangquan
Research Site, Ningbo
Research Site, Wenzhou
Lead Sponsor
AstraZeneca
INDUSTRY